Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.
Hyams
Jeffrey S
JS
Digestive Diseases and Nutrition Division, Connecticut Children's Medical Center, Hartford, Connecticut 06106, USA. jhyams@ccmckids.org
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002669:Child Welfare; D002986:Clinical Trials as Topic; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology*; D003657:Decision Making; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015122:Mercaptopurine / Q000008:administration & dosage / Q000627:therapeutic use*; D011788:Quality of Life; D012720:Severity of Illness Index
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D015122:Mercaptopurine; D001379:Azathioprine